You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    If you are an ASTM Compass Subscriber and this document is part of your subscription, you can access it for free at ASTM Compass
    STP1051

    Containment and Regulations for Safe Biotechnology

    Published: 01 January 1990


      Format Pages Price  
    PDF (280K) 17 $25   ADD TO CART
    Complete Source PDF (2.3M) 155 $55   ADD TO CART

    Cite this document

    X Add email address send
    X
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word


    Abstract

    The safe use of microorganisms for the manufacture of biological Pharmaceuticals has been demonstrated over several decades. Regulations, guidelines, and codes of practice are already available, and additional guidance is being published by a variety of organizations worldwide.

    The implications of these regulations are reviewed and their impact is described using examples of facility, equipment, and process design, with particular emphasis on containment.

    Keywords:

    bioprocessing, biotechnology, containment


    Author Information:

    Vranch, SP
    Head, Engineering and Fermentation, Wellcome Biotechnology Ltd., Beckenham, Kent


    Committee/Subcommittee: E48.01

    DOI: 10.1520/STP26067S